Erin Golembewski, Ph.D. - Publications
Affiliations: | 2006 | University of Maryland School of Medicine, Baltimore, MD, United States |
Area:
Pharmacology, Neuroscience Biology, Virology Biology| Year | Citation | Score | |||
|---|---|---|---|---|---|
| 2008 | Laing JM, Golembewski EK, Wales SQ, Liu J, Jafri MS, Yarowsky PJ, Aurelian L. Growth-compromised HSV-2 vector Delta RR protects from N-methyl-D-aspartate-induced neuronal degeneration through redundant activation of the MEK/ERK and PI3-K/Akt survival pathways, either one of which overrides apoptotic cascades. Journal of Neuroscience Research. 86: 378-91. PMID 17893911 DOI: 10.1002/Jnr.21486 | 0.559 | |||
| 2007 | Laing JM, Gober MD, Golembewski EK, Thompson SM, Gyure KA, Yarowsky PJ, Aurelian L. Corrigendum to "Intranasal Administration of the Growth-compromised HSV-2 Vector ΔRR Prevents Kainate-induced Seizures and Neuronal Loss in Rats and Mice". Molecular Therapy : the Journal of the American Society of Gene Therapy. 15: 1734. PMID 28182929 DOI: 10.1038/Sj.Mt.6300211 | 0.573 | |||
| 2007 | Golembewski EK, Wales SQ, Aurelian L, Yarowsky PJ. The HSV-2 protein ICP10PK prevents neuronal apoptosis and loss of function in an in vivo model of neurodegeneration associated with glutamate excitotoxicity. Experimental Neurology. 203: 381-93. PMID 17046754 DOI: 10.1016/J.Expneurol.2006.08.022 | 0.565 | |||
| 2006 | Laing JM, Gober MD, Golembewski EK, Thompson SM, Gyure KA, Yarowsky PJ, Aurelian L. Intranasal administration of the growth-compromised HSV-2 vector DeltaRR prevents kainate-induced seizures and neuronal loss in rats and mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 13: 870-81. PMID 16500153 DOI: 10.1016/J.Ymthe.2005.12.013 | 0.569 | |||
| Show low-probability matches. | |||||